Identification of PD1-mediated regulation of antitumor antigen response in patients with NSCLC using the trans vivo DTH assay

OBJECTIVES: Emerging evidence has shown a role for tumor antigen-specific regulation in cancer. Identifying individuals with pre-existing regulatory responses may be key to understand those who are more likely to respond to Programmed Death-1 (PD-1) or PD-1 Ligand 1 (PD-L1) checkpoint blockade. We h...

Descripción completa

Detalles Bibliográficos
Autores principales: Lema, Diego A, Jankowska-Gan, Ewa, Sethakorn, Nan, Burlingham, William, Leal, Ticiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292037/
https://www.ncbi.nlm.nih.gov/pubmed/32527929
http://dx.doi.org/10.1136/jitc-2019-000152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292037/
https://www.ncbi.nlm.nih.gov/pubmed/32527929
http://dx.doi.org/10.1136/jitc-2019-000152

Ejemplares similares